🟢 NOVO-B.CO is trading 2.2% up today as Medicare Wegovy pilot improves demand outlook

NOVO-B.CO is trading 2.2% up at $324.30 as investors react to stronger U.S. access prospects for Wegovy following a new Medicare pilot program.

• The pilot program allows GLP-1 weight-loss coverage with a $50 monthly co-pay, significantly improving sentiment regarding long-term demand and affordability.
• The gains extend a multi-day upward trend for the stock, which continues to support its valuation despite mildly weaker broader equity markets.